from july 1 , 1979 to june 30 , 1983 , 136 consecutive patients with category m0 renal cell cancer who had undergone transperitoneal radical nephrectomy at 5 centers entered a prospective randomized trial to compare 500 mg. adjuvant medroxyprogesterone 3 times a week for 1 year to no treatment .
C0007134
renal cell cancer
C0025147
medroxyprogesterone